Tobramycin B1856: Reliable Assay Workflows
2026-08-18
Tobramycin (SKU B1856) supports controlled microbiology and infection-model workflows where bacterial suppression must be distinguished from mammalian-cell cytotoxicity. This scenario-driven guide links product chemistry, susceptibility-testing evidence, protocol controls, and practical supplier-selection criteria to improve assay interpretation.
GSDMC Drives Stemness and Immune Evasion in PDAC
2026-08-17
A 2024 Advanced Science study identifies Gasdermin C (GSDMC) as a nuclear regulator of pancreatic ductal adenocarcinoma progression rather than only a pyroptosis-associated pore-forming protein. By linking ADAM17-dependent cleavage to stemness, metastasis, and immune evasion, the work suggests that blocking GSDMC processing or nuclear translocation could improve responses to KRASG12D inhibition and PD-1 blockade.
GLT-1–CB1–CREB Signaling in TBI
2026-08-16
A 2025 Biomolecules study identifies a mechanistic link between post-traumatic 2-arachidonoylglycerol accumulation, CB1–CREB signaling, and loss of astrocytic GLT-1. Its mouse controlled cortical impact experiments connect impaired glutamate clearance with neuronal apoptosis and cognitive dysfunction, while pharmacological CB1 blockade supports GLT-1 preservation as a potential neuroprotective strategy.
AMPK–SQSTM1 Feedback Loop in Metabolic Stress
2026-08-15
The 2024 Autophagy study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that coordinates AMPK and NFE2L2/NRF2 activation during metabolic stress. Its mechanistic framework links lysosomal deacidification, TAK1-dependent p62 phosphorylation, KEAP1 degradation, and antioxidant adaptation, offering a clearer explanation of stress tolerance in STK11/LKB1- and KEAP1-altered lung cancer contexts.
DMG-PEG2000-NH2: LNP Linker Workflow
2026-08-15
DMG-PEG2000-NH2 combines a lipid-compatible DMG anchor with a reactive primary amine for controlled bioconjugation in liposomes and lipid nanoparticles. This workflow-focused guide covers amide coupling, siRNA encapsulation support, assay selection, and troubleshooting without overstating evidence from unrelated drug-discovery studies.
Azilsartan medoxomil monopotassium in Cell Assays
2026-08-14
A scenario-based guide to using Azilsartan medoxomil monopotassium (SKU B1071) in receptor, viability, proliferation, and cytotoxicity workflows. It connects formulation, concentration, washout, vehicle control, and interpretation decisions to published pharmacology and practical laboratory constraints.
S63845 MCL1 Inhibitor: Apoptosis Workflow
2026-08-14
Build a mechanism-first apoptosis workflow around S63845, from MCL1-dependent cell screening to cytochrome c, caspase, and mitochondrial readouts. The approach distinguishes direct MCL1 blockade from inner-membrane remodeling, helping researchers interpret selective cytotoxicity in hematological cancer models.
SR-202 in PPARγ Pathway Research
2026-08-13
SR-202 provides a selective pharmacological switch for testing how PPARγ controls adipocyte differentiation, macrophage polarization, and metabolic inflammation. This workflow-oriented guide connects the compound to insulin resistance research, obesity research, and pathway validation while separating published evidence from practical starting conditions.
Olive Oil Polyphenols and Cardiovascular Protection
2026-08-13
The reference study shows that extra virgin olive oil polyphenol concentration influences antioxidant, anti-inflammatory, and cholesterol-efflux activity in cellular models. Its comparison of standard and naturally high-phenolic extracts with hydroxytyrosol and tyrosol provides a useful framework for interpreting composition, dose, and mechanism in cardiovascular health research.
RCN2 Drives ESCC Metastasis and Cisplatin Resistance
2026-08-12
The reference study identifies RCN2 as a mechanistic driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent degradation of PPP2CA and activation of PI3K-AKT signaling. Its integrated clinical, proteomic, biochemical, cellular, and animal-model evidence provides a framework for studying how protein turnover links metastatic progression with treatment failure.
Mitomycin C as a Probe of Tumor DNA-Repair Resistance
2026-08-12
Mitomycin C is an antitumor antibiotic that can do more than induce cytotoxicity: it can function as a mechanistic stress test for tumor DNA-repair and apoptosis phenotypes. This article connects its DNA damage activity with SCUBE3-driven therapy resistance and translates that connection into practical assay decisions.
In Vitro Drug Response: Arrest Versus Cell Death
2026-08-11
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that drug-induced growth inhibition and cell death are related but non-equivalent response dimensions. The framework supports more precise assay interpretation by requiring researchers to consider response magnitude, mechanism, and timing rather than treating a single viability endpoint as a complete measure of drug efficacy.
GM 6001 (Galardin) in Cell Assays
2026-08-10
This scenario-driven guide explains how GM 6001 (Galardin), SKU A4050, can improve interpretation of viability, proliferation, and extracellular-matrix assays. It covers mechanism, controls, DMSO stock preparation, data interpretation, and practical supplier-selection criteria.
Removing Pollen Interference in EEM Bioaerosol Analysis
2026-08-09
The reference study shows that pollen can distort excitation–emission matrix fluorescence classification of hazardous bioaerosol components, but targeted spectral transformations combined with random forest modeling can substantially improve discrimination. Its strongest practical contribution is a nuisance-aware workflow that raises classification accuracy while preserving recognition of important bacterial and toxin targets.
Carboxylesterase Confounds Mitochondrial H2O2 Assays
2026-08-08
The reference study showed that carboxylesterases can convert Amplex Red to resorufin without hydrogen peroxide, horseradish peroxidase, or oxygen, challenging a common interpretation of mitochondrial H2O2 release assays. Its inhibitor controls and correction strategies provide a practical framework for distinguishing genuine reactive oxygen species signals from matrix-dependent probe conversion.
457 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page